Skip to main content

Home/ Groups/ Dr. Goodyear
Rss Feed
Sort By: Most Recent | Popular Filter: All | Bookmarks | Topics Simple Middle
Nathan Goodyear

Effects of chronic estradiol treatment on the thyr... [BMC Res Notes. 2009] - PubMed re... - 0 views

www.ncbi.nlm.nih.gov/...19715616

estradiol thyroid function hyperthyroid hypothyroid

shared by Nathan Goodyear on 02 Feb 11 - No Cached
  • Nathan Goodyear on 02 Feb 11
     
    too little/ too much estrogen can negatively effect thyroid function; hormone balance one of the 5 points to health
Nathan Goodyear

Small Differences in Thyroid Function May Be Important for Body Mass Index and the Occu... - 0 views

jcem.endojournals.org/...4019

TSH thyroid weight obesity BMI

shared by Nathan Goodyear on 02 Feb 11 - No Cached
  • Nathan Goodyear on 02 Feb 11
     
    TSH doesn't have to be above normal for your weight to be negatively affected
Nathan Goodyear

Vitamin D3 Is More Potent Than Vitamin D2 in Human... [J Clin Endocrinol Metab. 2010] -... - 0 views

www.ncbi.nlm.nih.gov/...21177785

Vitamin D D3

shared by Nathan Goodyear on 03 Feb 11 - No Cached
  • Given its greater potency and lower cost, D3 should be the preferred treatment option when correcting vitamin D deficiency.
  • Nathan Goodyear on 03 Feb 11
     
    Vitamin D3 better absorbed than D2: and should be the preferential treatment in vitamin D deficiency
Nathan Goodyear

C-Reactive Protein as a Cardiovascular Risk Factor : More Than an Epiphenomenon? -- Lag... - 0 views

circ.ahajournals.org/...96

CRP cardiovascular disease

shared by Nathan Goodyear on 04 Feb 11 - No Cached
  • CRP constitutes an independent cardiovascular risk factor
  • Nathan Goodyear on 04 Feb 11
     
    CRP is an independent marker for future cardiovascular disease
Nathan Goodyear

Kidney International - Abstract of article: Inflammation enhances cardiovascular risk a... - 0 views

www.nature.com/...4490624a.html

inflammation CRP cardiovascular disease risk

shared by Nathan Goodyear on 04 Feb 11 - No Cached
  • Nathan Goodyear on 04 Feb 11
     
    Inflammation (point 5 of 5 points of wellness) increases CRP, which increases cardiovascular risk
Nathan Goodyear

Inflammation as a Cardiovascular Risk Factor -- Willerson and Ridker 109 (21 Supplement... - 0 views

circ.ahajournals.org/...II-2

inflammation cardiovascular CRP statin

shared by Nathan Goodyear on 04 Feb 11 - No Cached
  • Nathan Goodyear on 04 Feb 11
     
    statins do lower CRP reducing inflammation: one of primary benefits of statin therapy
Nathan Goodyear

Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Am... - 0 views

circ.ahajournals.org/...731

CRP cardiovascular risk women

shared by Nathan Goodyear on 04 Feb 11 - No Cached
  • CRP is a strong independent risk factor for cardiovascular disease that adds to the predictive value of risk models based on usual factors alone.
  • Nathan Goodyear on 04 Feb 11
     
    CRP is marker for cardiovascular risk in women
Nathan Goodyear

Inflammatory bio-markers and cardiovascular risk prediction - Blake - 2002 - Journal of... - 0 views

onlinelibrary.wiley.com/...full

inflammation CRP cardiovascular atherosclerosis

shared by Nathan Goodyear on 04 Feb 11 - No Cached
  • Inflammatory processes are now recognized to play a central role in the pathogenesis of atherosclerosis and its complications. Plasma levels of several markers of inflammation have been found to be associated with future cardiovascular risk in a variety of clinical settings.
  • Nathan Goodyear on 04 Feb 11
     
    inflammation (point 5 of the 5 points of wellness) shown to play central role in atherosclerosis.  See CRP
Nathan Goodyear

Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional... - 0 views

atvb.ahajournals.org/...1668

IL-6 CRP inflammation vascular

shared by Nathan Goodyear on 04 Feb 11 - No Cached
  • Nathan Goodyear on 04 Feb 11
     
    IL-6 and CRP reveal systemic vascular inflammation
Nathan Goodyear

Neuroleptic medications inhibit complex I of the e... [Ann Neurol. 1993] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...8098932

neuroleptics drugs Parkinson's disease mitochondria

shared by Nathan Goodyear on 05 Feb 11 - No Cached
  • Nathan Goodyear on 05 Feb 11
     
    neuroleptic drugs increase risk of Parkinson's disease by 20-40%
Nathan Goodyear

Coenzyme Q10 in neuromuscular and neurodegenerativ... [Curr Drug Targets. 2010] - PubMe... - 0 views

www.ncbi.nlm.nih.gov/...20017723

CoQ10 Alzheimer's Parkinson's ALS Dementia Neurodegenerative disease

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • a deficit in CoQ10 status has been determined in a number of neuromuscular and neurodegenerative disorders
  • A secondary loss of CoQ10 status following HMG-Coa reductase inhibitor (statins) treatment has be implicated in the pathophysiology of the myotoxicity associated with this pharmacotherapy
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 contributes to neurodegenerative disease, Parkinson's, Alzheimer's, ALS..., in some
Nathan Goodyear

Coenzyme Q10 in neurodegenerative diseases. [Curr Med Chem. 2003] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...12871093

CoQ10 Parkinson's disease

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • supplemental coenzyme Q(10) can slow the functional decline in these disorders, particularly Parkinson's disease.
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 may slow some aspects of Parkinson's disease
Nathan Goodyear

Coenzyme Q treatment of neurodegenerative diseases... [Mitochondrion. 2007] - PubMed re... - 0 views

www.ncbi.nlm.nih.gov/...17485247

CoQ10 Parkinson's ALS Huntington's Alzheimer's disease

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 shows promise in neurodegenerative disorders
Nathan Goodyear

Oxidative stress, mitochondrial dysfunction and ce... [J Neurol Sci. 2005] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...15896810

CoQ10 mitochondria neurodegenerative disease Alzheimer's Parkinsons MS ALS oxidative stress

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • There is significant evidence that the pathogenesis of several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, Friedreich's ataxia (FRDA), multiple sclerosis and amyotrophic lateral sclerosis, may involve the generation of reactive oxygen species (ROS) and/or reactive nitrogen species (RNS) associated with mitochondrial dysfunction
  • Nathan Goodyear on 07 Feb 11
     
    Mitochondrial dysfunction at heart of diseases such as Parkinson's, Alzheimers, MS, ALS..
Nathan Goodyear

Coenzyme Q10 administration and its potential for ... [Biofactors. 1999] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...10416039

CoQ10 neurodegenerative Alzheimer's Parkinson's ALS disease

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • hese studies therefore raise the prospect that administration of CoQ10 may be useful for the treatment of neurodegenerative diseases.
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 may be used to slow progression of neurodegenerative diseases such as Alzheimers, Parkinson's, ALS...
Nathan Goodyear

Coenzyme Q10 as a possible treatment for neurodege... [Free Radic Res. 2002] - PubMed r... - 0 views

www.ncbi.nlm.nih.gov/...12069110

coenzyme q10 CoQ10 Huntington's disease neurodegenerative

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • CoQ10 can significantly extend survival, delay motor deficits and delay weight loss and attenuate the development of striatal atrophy in a transgenic mouse model of HD
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 shown to shown to slow progression of the neurodegenerative disease: Huntington's disease
Nathan Goodyear

Coenzyme Q10 effects in neurodegenerative disease. [Neuropsychiatr Dis Treat. 2009] - P... - 0 views

www.ncbi.nlm.nih.gov/...19966907

coenzyme q10 neurodegenerative Parkinson's Alzheimer's Huntington's ALS

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 shown to be beneficial in treatment of neurodegenerative diseases, Parkinson's, Alzheimer's, ALS, Huntington's, in animal models
Nathan Goodyear

The evidence basis for coenzyme Q therapy in oxida... [Mitochondrion. 2007] - PubMed re... - 0 views

www.ncbi.nlm.nih.gov/...17485245

CoQ10 Parkinson's cardiac disease

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • In some mitochondrial diseases and other commoner disorders such as cardiac disease and Parkinson's disease low mitochondrial or tissue levels of CoQ10 have been demonstrated providing an obvious rationale for supplementation
  • Nathan Goodyear on 07 Feb 11
     
    Coq10 in Parkinson's disease and cardiac disease beneficial
Nathan Goodyear

Coenzyme Q10: a review of its promise as a neuropr... [CNS Spectr. 2007] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...17192765

CoQ10

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • Experimental studies in animal models suggest that CoQ10 may protect against neuronal damage that is produced by ischemia, atherosclerosis and toxic injury.
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 and neuroprotection
Nathan Goodyear

Friedreich's Ataxia: disease mechanisms, antioxida... [Biofactors. 2003] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...14695932

CoQ10 Vitamin E mitochondria

shared by Nathan Goodyear on 07 Feb 11 - No Cached
  • This therapy clearly showed a rapid and sustained increase in the energy generated by the FRDA heart muscle, nearly returning to normal levels
  • Nathan Goodyear on 07 Feb 11
     
    CoQ10 and Vitamin E shown to improve mitochondrial function in clients with Friedreich's Ataxia
« First ‹ Previous 341 - 360 Next › Last »
Showing 20▼ items per page
Join this group